“Onchocerciasis (River Blindness) - Pipeline Review, H1 2012”

Scope

- A snapshot of the global therapeutic scenario for Onchocerciasis (River Blindness).
- A review of the Onchocerciasis (River Blindness) products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the Onchocerciasis (River Blindness) pipeline on the basis of route of administration and molecule type.
- Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development progress.
- Key discontinued pipeline projects.
- News and deals relating to the products.

Reasons to Buy

- Identify and understand important and diverse types of therapeutics under development for Onchocerciasis (River Blindness).
- Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
- Plan mergers and acquisitions effectively by identifying players with the most promising pipeline.
- Devise corrective measures for pipeline projects by understanding Onchocerciasis (River Blindness) pipeline depth and focus of Onchocerciasis (River Blindness) therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.


For more information visit http://www.researchandmarkets.com/research/r744sq/onchocerciasis_ri

Source: Global Markets Direct